NewsRx

Search our medical news database

Hepatitis Weekly

Susan Hasty, Publisher

Table of Contents . . . October 31st, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Hepatitis Weekly | Other Publications

Hepatitis B Transmission - Viral heterogeneity may produce intrauterine hepatitis B virus infection

Liver Transplantation - Thymoglobulin may prevent liver graft rejection and hepatitis C recurrence

Prison Health - Hepatitis B and C virus infections flourish among reincarcerated females

Transplant Medicine - Hepatitis B immunoglobulins avert acute rejection after liver transplantation

Transplant Medicine - Hepatitis C HVR1 quasispecies variants and CD81 change after liver transplants

Cardiology - Divergent factors control hepatitis C-related cardiomyopathy

Cell Biology - The mitogenic effect of TWEAK in liver oval cells may foster liver injury

Chronic Hepatitis B - The hepatitis B virus genome changes vary in youth who receive lamivudine

Clinical Trials - Trial of human monoclonal antibodies treatment for hepatitis C initiated

DNA Research - The expression of neuritin, a GPI-anchored protein, increases with liver development

Diabetes Risk Factors - Steatotic grafts raise the risk for new-onset diabetes in liver transplant patients

Diagnostics - Alanine aminotransferase measures liver status in hepatitis C-positive renal transplant recipients

Diagnostics - Albumin dialysis may improve mitochondrial function in patients with hepatitis C

Diagnostics - Researchers' findings advance diagnostics research

Drug Development - Hepatitis C clinical trial initiated to test NeuGene antisense compound

Drug Development - Interim results in phase II trial of Virostat show the drug is active against hepatitis C

Drug Resistance - Expression of drug transporters does not correlate to their expression in the intestine and liver

Finance - Pharmaceutical company raises GBP 750,000 for preclinical development of interferon alpha-8

Gene Research - Australian broad patent issued covering siRNAs targeting Huntington disease

Hepatitis B Vaccine - Booster vaccination against hepatitis B not necessary for long-term protection

Hepatitis B Virus - Drug resistant highly replicative hepatitis B strains associate with acute exacerbations

Hepatitis C - Genotype 1 hepatitis C virus patients treated with VX-950 reduce alanine aminotransferase levels

Hepatitis C Risk Factors - Non-commercial tattooing raises the risk for hepatitis C among non-injecting drug users

Hepatitis C Virus - New research in the area of hepatitis c virus detailed

Hepatitis C Virus - Shorter course of combination therapy approved in E.U. for some hepatitis C patients

Hepatology - Anthropometric indices parallel liver pathology in non-alcoholic fatty liver disease

Imaging - High-resolution spectroscopy successfully assesses liver biopsy samples

Liver Disease - Feedback loop found that could forestall liver damage

Liver Transplantation - Hepatitis C viral load recedes when immunosuppressive therapy is switched

Oncology - Southern African Blacks with hepatitis B-related liver cancer lack beta-catenin gene mutations

Renal Transplantation - Hepatitis B surface antigen-positive renal donors support similarly infected recipients

Renal Transplantation - Hepatitis C disappears after immunosuppressive therapy ceases

Stroke - Eyes may provide a window to future strokes

Tissue Engineering - Extracellular matrix-enriched polymeric scaffolds favor hepatocyte survival

Tissue Engineering - Liver organogenesis system shows higher levels of hepatic function

Transplant Medicine - Hepatitis B core antibody-positive kidneys could expand donor pools

Transplant Medicine - Mycophenolate mofetil monotherapy benefits liver transplant recipients

Transplant Medicine - Researchers describe findings in transplant medicine studies

Vaccine Policy - Immunocompetent travelers rarely require hepatitis A or B booster shots

Virology - Hepatitis C virus RNA in saliva does not reflect oral health or viral load

Virology - Hepatitis C virus core protein-mediated cell cycle alterations may trigger disease

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook